Next, we investigated the expression of p300 and FLT3 in four patient-derived AML samples harboring FLT3-ITD mutation obtained at the time of diagnosis without prior treatment (patient information is provided in Table S3). This evidence concerns the gene FLT3 and acute myeloid leukemia.